Subscribe to RSS
DOI: 10.1055/s-2005-861811
Regioselective Synthesis of Pyrrolo[2,3-d]pyrimidine Derivatives by Amine Oxide Rearrangement
Publication History
Publication Date:
29 March 2005 (online)
Abstract
Regioselective synthesis of biologically important pyrrolo[2,3-d]pyrimidine derivatives 4a-h in 75-82% yields are reported. The applied conditions of the less studied rearrangement are the oxidation of 6-N-(4-aryloxybut-2-yn-1-yl)-N-methyl(or ethyl)amino-1,3-dimethyluracils 3a-h with m-chloroperoxybenzoic acid at 0-5 °C for one hour and then stirring at room temperature for 10-12 hours. Compounds 3a-h are prepared by the reaction of 1,3-dimethyl-6-chlorouracil (1) with different (4-aryloxybut-2-yn-1-yl)-N-methylamines or (4-aryloxybut-2-yn-1-yl)-N-ethylamines 2 in refluxing ethanol for 12-14 hours.
Key words
6-alkylamino-1,3-dimethyluracils - m-chloroperoxybenzoic acid - amine oxide rearrangement - pyrrolo[2,3-d]pyrimidines - [2,3] and [3,3] sigmatropic rearrangement
- 1
Gupta PK.Daunert S.Nassiri MR.Wotring LL.Drach JC.Townsend LB. J. Med. Chem. 1989, 32: 402 - 2
Gupta PK.Nassiri MR.Coleman LA.Wotring LL.Drach JC.Townsend LB. J. Med. Chem. 1989, 32: 1420 - 3
Bhattacharya BK.Ojwang JO.Rando RF.Huffman JH.Revankar GR. J. Med. Chem. 1995, 38: 3957 - 4
Chin JE.Hatfield CA.Winterrowd GE.Krzesicki RF.Shull KL.Fidler SF.Kolbasa KP.Brashler JR.Griffin RL.Fleming WE.Justen JM.Banitt LS.Bundy GL.Richards IM. J. Pharm. Exp. Ther. 1999, 290: 188 - 5
Miyasaka T.Tanaka H.Baba M.Hayakawa H.Walker RT.Balzarini J.DeClercq E. J. Med. Chem. 1989, 32: 2507 - 6
Baba M.Tanaka H.DeClercq E.Pauwels R.Balzarini J.Schols D.Nakashima H.Perno CF.Walker RT.Miyasaka T. Biochem. Biophys. Res. Commun. 1989, 165: 1375 - 7
DeClercq E. Med. Res. Rev. 1993, 13: 229 -
8a
Gallo RC. Sci. Am. 1986, 255: 78 -
8b
Gallo RC. Sci. Am. 1987, 256: 38 -
9a
Heidelberger C. Pyrimidine and Pyrimidine Antimetabolites in Cancer MedicineHolland JF.Frei E. Lea and Febiger; Philadelphia: 1984. p.801 -
9b
Taylor EC.Liu B. J. Org. Chem. 2003, 68: 9938 - 10
DeClercq E.Descamps J.Somer PD.Barr PJ.Jones AS.Walker RT. Proc. Natl. Acad. Sci. USA 1979, 76: 2947 - 11
Heidelberger C.King DH. In Antiviral Agents in Pharmacology and Therapeutics Vol. 6:Shugar D. Pergamon; Oxford: 1979. p.427 - 12
Mitsuya H.Weinhold KJ.Furman PA.St. Clair MH.Lehrman SN.Gallo RC.Bolognesi D.Barry DW.Broder S. Proc. Natl. Acad. Sci. U.S.A. 1985, 82: 7096 - 13
Fischl MA.Richman DD.Grieco MH.Gottlieb MS.Volberdin PA.Laskin OL.Leedom JM.Groopman JE.Mildvan D.Schooley RT.Jackson GG.Durack DT.King D. N. Engl. J. Med. 1987, 317: 185 - 14
Griengl H.Bodenteich M.Hayden W.Wanek E.Streicher W.Stutz P.Bachmayer H.Ghazzouli I.Rosenwirth B. J. Med. Chem. 1985, 28: 1679 - 15
Macilwain C. Nature 1993, 365: 378 -
16a
Kundu NG.Das P. J. Chem. Soc., Chem. Commun. 1995, 99 -
16b
Botta M.Saladino R.Lamba D.Nicoletti R. Tetrahedron 1993, 49: 6053 -
17a
Majumdar KC.Mukhopadhyay PP. Synthesis 2003, 920 -
17b
Majumdar KC.Das U.Jana NK. J. Org. Chem. 1998, 63: 3550 -
17c
Majumdar KC.Basu PK.Mukhopadhyay PP.Sarkar S.Ghosh SK.Biswas P. Tetrahedron 2003, 59: 2151 -
18a
Majumdar KC.Sarkar S.Bhattacharrya T. Tetrahedron 2003, 59: 4309 -
18b
Majumdar KC.Bhattacharrya T. Synthesis 2001, 4309 -
18c
Majumdar KC.Mukhopadhyay PP. Synthesis 2004, 1864 -
19a
Hillard JB.Reddy KV.Majumdar KC.Thyagarajan BS. Tetrahedron Lett. 1974, 1999 -
19b
Hillard JB.Reddy KV.Majumdar KC.Thyagarajan BS. J. Heterocycl. Chem. 1974, 11: 369 -
19c
Thyagarajan BS.Majumdar KC. J. Heterocycl. Chem. 1975, 12: 43 -
20a
Majumdar KC.Chattopadhyay SK. J. Chem. Soc., Chem. Commun. 1987, 524 -
20b
Majumdar KC.Chattopadhyay SK.Khan AT. J. Chem. Soc., Perkin Trans. 1 1989, 1285 -
20c
Majumdar KC.Ghosh SK. J. Chem. Soc., Perkin Trans. 1 1994, 2889 -
21a
Majumdar KC.Jana GH.Das U. J. Chem. Soc., Chem. Commun. 1997, 517 -
21b
Majumdar KC.Jana GH.Das U. J. Chem. Soc., Perkin Trans. 1 1997, 1229 -
21c
Majumdar KC.Samanta SK. Tetrahedron Lett. 2002, 43: 2119 - 22
Majumdar KC.Kundu UK.Ghosh S. Tetrahedron 2002, 58: 10309